GRAIL Inc. - Illumina's Divested Holy Grail [Seeking Alpha]
GRAIL, Inc. (GRAL)
Company Research
Source: Seeking Alpha
Divestiture of GRAIL by Illumina offers investors $8B valuation foundation. TAM valuation implies substantial upside, assuming eventual FDA approval and moderate market penetration. Pablo Blazquez Dominguez/Getty Images News GRAIL Inc. Company Overview GRAIL Inc. ( GRAL ) is a commercial-stage healthcare company that produces multi-cancer early detection (MCED) screening tests. The Company believes that early screening of cancer can help relieve the burden of cancer in This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future
Show less
Read more
Impact Snapshot
Event Time:
GRAL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRAL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRAL alerts
High impacting GRAIL, Inc. news events
Weekly update
A roundup of the hottest topics
GRAL
News
- Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 [Yahoo! Finance]Yahoo! Finance
- GRAIL: Making Strides In Cancer Detection [Seeking Alpha]Seeking Alpha
- GRAIL to Present at the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- GRAIL (NASDAQ:GRAL) was given a new $110.00 price target on by analysts at Morgan Stanley.MarketBeat
- GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire